| 2.99 -0.24 (-7.43%) | 10-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.66 |
1-year : | 3.86 |
| Resists | First : | 3.13 |
Second : | 3.3 |
| Pivot price | 3.08  |
|||
| Supports | First : | 2.85 |
Second : | 2.37 |
| MAs | MA(5) : | 3.14 |
MA(20) : | 3.06 |
| MA(100) : | 3.55 |
MA(250) : | 4.27 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 65.8 |
D(3) : | 74.6 |
| RSI | RSI(14): 42.1 |
|||
| 52-week | High : | 6.6 | Low : | 2.85 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ KRMD ] has closed above bottom band by 21.6%. Bollinger Bands are 41.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.23 - 3.25 | 3.25 - 3.26 |
| Low: | 2.95 - 2.97 | 2.97 - 2.98 |
| Close: | 2.96 - 2.99 | 2.99 - 3.01 |
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Sat, 24 Oct 2026
KORU Medical Systems, Inc. Estimates – NASDAQ:KRMD - TradingView
Fri, 23 Oct 2026
Form 4 KORU Medical Systems Inc: R. John Fletcher (Director, Chairman of the Board) For: 1 October - Investing.com Nigeria
Wed, 21 Oct 2026
KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026 - BioSpace
Sat, 12 Sep 2026
Insider Spends US$101k Buying More Shares In KORU Medical Systems - Simply Wall St
Sat, 22 Aug 2026
KORU Medical Systems Stock Selloff Offers An Opportunity (NASDAQ:KRMD) - Seeking Alpha
Wed, 05 Aug 2026
KORU Medical Systems Q2 Earnings Call Highlights - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 46 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 8.2 (%) |
| Held by Institutions | 56.4 (%) |
| Shares Short | 907 (K) |
| Shares Short P.Month | 884 (K) |
| EPS | -0.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.38 |
| Profit Margin | -4.1 % |
| Operating Margin | 5.1 % |
| Return on Assets (ttm) | -3.9 % |
| Return on Equity (ttm) | -10.6 % |
| Qtrly Rev. Growth | 18.2 % |
| Gross Profit (p.s.) | 0.61 |
| Sales Per Share | 0.98 |
| EBITDA (p.s.) | -0.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -74.75 |
| PEG Ratio | 0 |
| Price to Book value | 7.66 |
| Price to Sales | 3.04 |
| Price to Cash Flow | 98.79 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|